Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia: A single center experience

Annals of Hematology

Volumn 80, Issue 5, 2001, Pages 267-271

  Castagnola, C ^a   Alessandrino, E P ^a   Lunghi, M ^a   Bernasconi, P ^a   Della Porta, M ^a   Mangiacavalli, S ^a   Colombo, A ^a   Corso, A ^a   Pagnucco, G ^a   Lazzarino, M ^a   Bernasconi, C ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

AML; Autologous transplantation; Peripheral blood progenitor cells

Indexed keywords

CD34 ANTIGEN; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; MITOXANTRONE; MYELOABLATIVE AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW PURGING; CANCER RECURRENCE; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKAPHERESIS; LEUKOCYTE COUNT; MALE; MONONUCLEAR CELL; NEUTROPHIL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SALVAGE THERAPY; THROMBOCYTE COUNT;

ACUTE DISEASE; ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; CYTARABINE; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; TRANSPLANTATION, AUTOLOGOUS;

EID: 0034981083     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770000277     Document Type: Article

References (21)

1. Autologous or allogenic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia
2. Adult AML: The role of chemotherapy intensity and duration. Two studies of the AML cooperative group
3. Long-term outcome of adults with acute myelogenous leukemia: Result of a prospective, randomized study with a minimal follow-up of 7 years
4. Autologous stem cell transplantation in acute myelocytic leukemia
5. Post remission treatment of acute myelogenous leukemia
6. Autologous bone marrow transplantation in acute myeloid leukemia in first remission: Results of a Dutch prospective study
7. Autologous bone marrow transplant in acute leukemia in first remission
8. Randomized trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients
9. Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?
10. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells
11. Graft-versus-leukemia reaction after bone marrow transplantation
12. Randomized comparison of addition of autologous bone marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: Results of MRC AML10 trial. UK Medical Research Council Leukaemia Working Parties
13. CD34-positive cells: Biology and clinical applications
14. Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors
15. Peripheral blood stem cells in acute myeloid leukemia: Biology and clinical applications
16. Evaluation of leukaemic contamination in peripheral blood stem cell harvests by reverse transcriptase polymerase chain reaction
17. Quantitative analysis of AML1/ETO transcripts in peripheral blood stem cell harvest from patients with t(8;21) acute myelogenous leukaemia
18. Relapse after autografting with peripheral blood stem cells
19. Peripheral blood stem cell transplantation may result in increased relapse of acute myeloid leukemia due to reinfusion of a higher number of malignant cells
20. Autologous peripheral blood stem cell transplantation for acute myelogenous leukemia
21. Molecular remission in PML/RAR alpha positive acute promyelocytic leukemia by combined all-tran retinoic acid and idarubicin (AIDA) therapy